Back to Journals » Clinical Ophthalmology » Volume 10

The acute phase of inflammatory response involved in the wound-healing process after excimer laser treatment

Authors Resan M, Vukosavljevic M, Vojvodic D, Pajic-Eggspuehler B, Pajic B

Received 5 February 2016

Accepted for publication 8 March 2016

Published 30 May 2016 Volume 2016:10 Pages 993—1000

DOI https://doi.org/10.2147/OPTH.S105880

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Gokcen Gökçe

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser


Mirko Resan,1,2 Miroslav Vukosavljevic,1,2 Danilo Vojvodic,2,3 Brigitte Pajic-Eggspuehler,4 Bojan Pajic2,4–6

1Eye Clinic, Military Medical Academy, Belgrade, Serbia; 2Faculty of Medicine of the Military Medical Academy, University of Defense, Belgrade, Serbia; 3Department for Clinical and Experimental Immunology, Institute for Medical Research, Military Medical Academy, Belgrade, Serbia; 4Eye Clinic ORASIS, Swiss Eye Research Foundation, Reinach AG, Switzerland; 5Department of Physics, Faculty of Science, University of Novi Sad, Novi Sad, Serbia; 6Division of Ophthalmology, Department of Clinical Neurosciences, University Hospitals of Geneva, Switzerland

Purpose: To evaluate the participation of proinflammatory cytokines in the acute phase of corneal wound-healing response after excimer laser treatment.
Methods: The study included 68 myopic eyes up to -3.0 diopters divided into two groups: 1) eyes treated with laser in situ keratomileusis (LASIK) (n=31) and 2) eyes treated with photorefractive keratectomy (PRK) (n=37). Each group was then divided into three subgroups based on tear sampling times: before (0 hours), 1 hour after, and 24 hours after treatment. The tear fluid was sampled from lower lateral tear meniscus using a cellulose microsurgical sponge. The levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, and IL-8 in tear fluid were determined by flow cytometry method.
Results: Statistical significance was observed in the concentrations of TNF-α (P=0.0421) and IL-1β (P=0.0225) between samples collected 1 and 24 hours after PRK treatment in favor of samples collected 1 hour after treatment. IL-6 concentration changes showed a significant increase in the PRK group in both time intervals following treatment compared to pretreatment (0 hour/1 hour, P=0.0031; 0 hour/24 hours, P=0.0059). For IL-8 concentrations, significant differences were observed between control and experimental groups in samples collected 1 hour after LASIK and 1 hour after PRK treatment (P<0.001 for both groups), and IL-8 concentrations between control and experimental groups in samples collected 24 hours after LASIK and 24 hours after PRK treatment were greater after PRK treatment (P=0.0005). Comparison of average concentration values of proinflammatory cytokines in all the tested samples between LASIK and PRK groups showed significantly higher levels of IL-1β in the LASIK group 24 hours after treatment (P=0.0134), and of IL-6 in the PRK group 24 hours after treatment (P=0.0031).
Conclusion: The acute phase of corneal wound healing after excimer laser treatment is defined by an intensive inflammatory response. After PRK treatment, there were increased concentrations of TNF-α and IL-1β in tear samples 1 hour after treatment, IL-6, 1 and 24 hours after treatment, and IL-8, 1 and 24 hours after treatment. After LASIK treatment, there were increased concentrations of IL-8 in tear samples 1 hour after treatment and IL-1β, 24 hours after treatment. Both PRK and LASIK methods are characterized with a significant inflammatory response. However, tear findings following PRK method showed more intensive inflammatory response than the findings after LASIK method.

Keywords:
LASIK, PRK, tears, proinflammatory cytokines, wound healing

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]